AusBiotech partners with Tenmile
Designed to support Australia’s homegrown life sciences innovation, AusBiotech has announced a strategic partnership with specialist health technology investor Tenmile. Acknowledging that while there is no shortage of ambitious founders, talented researchers and Australian breakthroughs, many stall before they find the capital, the partnerships, and the pathways to market they need, the partnership is geared towards moving world-class Australian science from lab to the patients who need it most, both locally and globally.
“Partnerships are in Tenmile’s DNA and it’s an important part of our mandate to support and build the broader commercialisation ecosystem that Australian health innovation needs,” Tenmile CEO Dr Steve Burnell said. “Our collaboration with AusBiotech is built around creating more of those connections, especially around key areas like anti-microbial resistance, cancer, AI, women’s health and health equity. Together we want to make sure Australia achieves the impact it deserves as a serious player on the global life sciences stage.”
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
Statins reduce heart attack and stroke risk in older people
It has previously been unclear whether statins were effective in reducing heart attack and stroke...
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
